VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
199,106MODERNA
36,710JANSSEN
5,381PFIZER\BIONTECH
2,555GLAXOSMITHKLINE BIOLOGICALS
1,469UNKNOWN MANUFACTURER
897MERCK & CO. INC.
627SEQIRUS, INC.
112DYNAVAX TECHNOLOGIES CORPORATION
91SANOFI PASTEUR
75NOVARTIS VACCINES AND DIAGNOSTICS
40EMERGENT BIOSOLUTIONS
14PAXVAX
12TEVA PHARMACEUTICALS
12PROTEIN SCIENCES CORPORATION
9PFIZER\WYETH
4BERNA BIOTECH, LTD.
4SMITHKLINE BEECHAM
3INTERCELL AG
1MEDIMMUNE VACCINES, INC.
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL7,949
7,473
2,547
1,506
1,187
1,051
1,049
s0294561,043
866
IMM209861
816
UT7065MA766
657
579
U62828AA563
557
538
U6737AA516
515
S034636506
4F472471
458
P100253275449
444
276563436
429
418
4BH32414
MENVEO404
PP9L5362
UJ446AA337
319
306
290
271
49TM3270
R1B252M253
4F472179
933622147
C5763AA144
CW3116134
3Y7NL126
UNK114
113
ARBA141A105
104
103
96
300057A90
79
1F4EB73
R1B743M62
56
UJ090AA55
51
UH894AB46
45
UNK44
UNK42
42
EJ168638
Unknown36
35
34
32
32
26
el128424
24
A115A22
22
EN620222
21
UNK20
20
19
Z127A19
19
17
JEV18K95E15
12
111798PI12
10
A739088
No batch number8
3333324181078
6
6
TAR356
5
5
U6935AA5
UNK5
4
unknown4
3
2
55RB72
2
2
2
2
2
U7124AA2
JEV18A68E2
2
ABYB05BA1
1
1
1
1
AMVA436A1
1
1
TJ3521
A130A; VIS give1
1
U7140BB1
1
1
SP UP016AA1
1
1808P08802/ESV01
037K20A300,947
EL1284288,578
57,766
1,432

Incidents per State

State Total
82,750
CA62,821
FL38,209
TX36,512
NY34,921
PA23,646
IN23,622
IL20,597
MI19,590
OH19,426
NJ18,413
NC16,769
GA15,932
WA15,351
VA15,234
MA14,876
AZ14,206
MN12,940
MD12,656
CO11,908
WI11,425
MO10,240
TN9,685
OR8,768
KY8,437
CT8,300
SC6,700
OK6,293
AL5,692
LA5,025
IA4,825
KS4,821
UT4,637
NV4,374
NM3,967
AR3,807
ME3,161
NH3,096
NE2,918
MS2,859
ID2,785
WV2,469
HI2,459
PR2,417
MT2,414
RI2,076
DE1,868
AK1,830
VT1,734
DC1,715
ND1,388
SD1,269
WY866
GU118
VI69
AS47
MP29
MH8
XB6
FM4
QM3
XV2
XL1

ID: 1811167
Sex: F
Age:
State: MO

Vax Date: 04/21/2021
Onset Date: 04/21/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: Within minutes of vaccine I felt burning in back of through, difficulty taking deep breathe, and rapid heart beat.; Within minutes of vaccine I felt burning in back of through, difficulty taking deep breathe, and rapid heart beat; Within minutes of vaccine I felt burning in back of through, difficulty taking deep breathe, and rapid heart beat; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 21Apr2021 at 09:45 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL), paracetamol (TYLENOL), ibuprofen (ADVIL) and estradiol (ESTROGEN) taken for an unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 21Apr2021 at 09:45 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. On 21Apr2021, within minutes of vaccine, the patient experienced burning in back of through, difficulty taking deep breath, and rapid heartbeat. The events did not result in a visit to the doctors or other healthcare professional office/clinic, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events within minutes of vaccine the patient felt burning in back of through, difficulty taking deep breathe, and rapid heartbeat was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: ADDERALL; TYLENOL; ADVIL [IBUPROFEN]; ESTROGEN.

Current Illness:

ID: 1811168
Sex: M
Age:
State:

Vax Date: 10/18/2019
Onset Date:
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Name: Bone marrow biopsy; Result Unstructured Data: Test Result:No results reported; Test Name: Haemoglobin; Result Unstructured Data: Test Result:Low

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: Hgb low; Woozy; Headache; This is a spontaneous report from a contactable consumer (Patient). An 87-year-old male patient received second dose of bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection, Batch/Lot number was not reported), via an unspecified route of administration in Feb2021 as dose 2, single for covid-19 immunization. Patient received ruxolitinib phosphate (JAKAFI), oral from 18Oct2019 (Batch/Lot number was not reported) and ongoing, at 10 mg, 2x/day for myelofibrosis. Medical history included ongoing essential thrombocythemia. Concomitant medications included furosemide (LASIX [FUROSEMIDE]), levothyroxine sodium (SYNTHROID), cyclosporine (CYCLOSPORINE) taken for an unspecified indication, start and stop date were not reported. The patient received first dose of bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as dose 1, single for covid-19 immunization. On an unspecified date in 2021, the patient experienced Hgb low, woozy and headache. The patient underwent lab tests and procedures which included biopsy bone marrow result was unknown and haemoglobin was low on an unspecified date. The clinical outcome of the event Hgb low was not recovered and events woozy and headache was recovered in unspecified date in 2021. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: LASIX [FUROSEMIDE]; SYNTHROID; CYCLOSPORINE; JAKAFI

Current Illness: Essential thrombocythemia

ID: 1811169
Sex: M
Age:
State: CA

Vax Date: 04/16/2021
Onset Date: 04/18/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: Swelling on left lateral chest and left flank; Soreness on left lateral chest and left flank; swollen lymph node in left anterior neck; This is a spontaneous report from a contactable consumer, the patient. An 18-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0161) via an unspecified route of administration in the arm left on 16Apr2021 at 12:30 (at the age of 18-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient had no known allergies. Concomitant medications included protein powder received within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18Apr2021 at 00:00, one and half day after vaccine, the patient experienced, soreness and swelling on left lateral chest and left flank. The patient did not have redness or warmth, swelling on arm or axilla; swelling and tenderness on left side had increased over the last few days; also swollen lymph node in left anterior neck. The events resulted in emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events swelling on left lateral chest and left flank, soreness on left lateral chest and left flank and swollen lymph node in left anterior neck was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1811170
Sex: M
Age:
State: OH

Vax Date: 04/19/2021
Onset Date: 04/19/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data: Test Date: 202104; Test Name: blood work; Result Unstructured Data: Test Result:unknown results

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: broke out in hives/ bumps; This is a spontaneous report from a contactable consumer (patient). A 32-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: EW0150, Expiration Date: 31Jul2021), via an unspecified route of administration, administered in the left arm on 19Apr2021 (at the age of 32 years old) as dose 1, single for COVID-19 immunisation. The patient has no medical history. The patient's concomitant medications were not reported. On 19Apr2021, the patient broke out in hives and went to the emergency room. He also reported that he took the vaccine on 19Apr2021 and once he went to home he was taking out with bumps, the real bumps and he went to the emergency room. The patient underwent lab tests and procedures which included blood work: unknown results on an unspecified date in Apr2021. The patient was given medications for bumps and the hives which included prednisone 20mg and IC famotidine 20mg (as reported). The patient was improving (recovering) from the event. No follow-up attempts are possible. No further information is expected

Other Meds:

Current Illness:

ID: 1811171
Sex: F
Age:
State: CA

Vax Date: 04/08/2021
Onset Date: 04/09/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Rash covering face and upper chest; including headaches; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration in the left arm on 08Apr2021 at 14:00 (at the age of 48-year-old) as a single dose for COVID-19 immunisation. Medical history included multiple sclerosis, post-concussion syndrome and penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. On 09Apr2021, the patient experienced rash covering face, upper chest including headaches. The events did not result in doctor or other healthcare professional office or clinic visit, emergency room or department or urgent care. No therapeutic measures were taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events rash covering face and upper chest including headaches were recovering at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1811172
Sex: F
Age:
State: NY

Vax Date: 04/03/2021
Onset Date: 04/03/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data: Test Date: 20210407; Test Name: COVID-19 virus test; Result Unstructured Data: Test Result:Negative

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: Itchy raised red rash/hives began within 24 hours and lasted approximately 10 days. Located multiple places on body. Arms, legs, torso both front and back.; Itchy raised red rash/hives began within 24 hours and lasted approximately 10 days. Located multiple places on body. Arms, legs, torso both front and back.; Itchy raised red rash/hives began within 24 hours and lasted approximately 10 days. Located multiple places on body. Arms, legs, torso both front and back.; Itchy raised red rash/hives began within 24 hours and lasted approximately 10 days. Located multiple places on body. Arms, legs, torso both front and back.; Also developed a bad sore throat - like rocks in the throat started about 8 hours after the vaccine shot. They went away by the next morning.; Also very tired for a day; Sore in the arm where the injection was given for a couple of days.; This is a spontaneous report from a non-contactable consumer, the patient. A female patient of unknown age received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 03Apr2021 as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history and no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication taken within two weeks of vaccination included ethinylestradiol, drospirenone (YASMIN) for unknown indication on unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Apr2021, the patient experienced itchy raised red rash and hives that began within 24 hours and lasted approximately 10 days. They were located in multiple places on body. Arms, legs, torso both front and back. The patient also developed a bad sore throat - like rocks in the throat that started about 8 hours after the vaccine shot. They went away by the next morning. On 03Apr2021 the patient experienced sore in the arm where the injection was given for a couple of days. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had been tested for COVID-19. On 07Apr2021, the patient underwent COVID-19 virus test and the result was negative. The clinical outcome of the event developed a bad sore throat - like rocks in the throat started about 8 hours after the vaccine shot, they went away by the next morning and very tired for a day was resolved on 04Apr2021. The clinical outcome of the event itchy raised red rash and hives began within 24 hours and lasted approximately 10 days, located in multiple places on body, arms, legs, torso both front and back was resolved on an unknown date in Apr2021. The clinical outcome of the event sore in the arm where the injection was given for a couple of days was resolved on an unknown date in Apr2021. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: YASMIN

Current Illness:

ID: 1811173
Sex: M
Age: 36
State:

Vax Date: 10/21/2021
Onset Date: 10/22/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: Fatigue, vomiting, fever, chills, for 1 day, the following day extremely swollen lymph nodes under left arm

Other Meds:

Current Illness:

ID: 1811175
Sex: F
Age: 36
State:

Vax Date: 10/01/2021
Onset Date: 10/22/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies: Fragrances; chemicals; gluten; dairy

Symptom List: Pharyngeal swelling

Symptoms: Racing heartbeat and heart palpitations; insomnia; anxiety; brain fog; suicidal ideation

Other Meds: Lysine

Current Illness:

ID: 1811176
Sex: F
Age: 40
State: NY

Vax Date: 10/21/2021
Onset Date: 10/22/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: None

Allergies: Latex

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: Right axillary area swollen and very tender to touch or movement. Area feels inflamed. Tylenol and Aleve used as directed. Ice packs placed. Pain and swelling still present 24 hours later but slightly less discomfort.

Other Meds: Tylenol 1000mg

Current Illness: None

ID: 1811177
Sex: U
Age: 23
State:

Vax Date: 09/09/2021
Onset Date: 09/22/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: Headache

Other Meds:

Current Illness:

ID: 1811179
Sex: F
Age: 41
State: NC

Vax Date: 03/08/2021
Onset Date: 03/12/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data: all blood work btw 3/14 and today

Allergies: Sulfa based meds, penicillin, amoxycillin

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: I developed subacute thyroiditis 5 days after vaccination. I had pain and inflammation in my thyroid, neck and mouth. My THS , T3 and T4 indicated hyperthyroidism and subsequent hypothyroidism. I continue to take medication for hypothyroidism at 7 months and was feeling extreme fatigue, brain fog and lightheaded/ill until abt 8 weeks ago.

Other Meds: None

Current Illness: None

ID: 1811180
Sex: F
Age:
State: MO

Vax Date: 04/20/2021
Onset Date: 04/20/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: This is a spontaneous report from a non-contactable other healthcare professional, the patient. A 41-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the right arm on 20Apr2021 at 12:15 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included duloxetine hydrochloride (CYMBALTA) and esomeprazole sodium (NEXIUM); both for an unknown indication from an unknown date and unknown if ongoing. The patient previously took promethazine (PHENERGAN) and experienced drug allergy. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8721) via an unspecified route of administration in the right arm on 30Mar2021 at 12:15 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. On 20Apr2021, the patient experienced headache, fatigue, nausea and diarrhea. The events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. It was unknown whether any therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events headache, fatigue, nausea and diarrhea were unknown at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds: CYMBALTA; NEXIUM [ESOMEPRAZOLE SODIUM.]

Current Illness:

ID: 1811181
Sex: F
Age:
State: NJ

Vax Date: 03/17/2021
Onset Date: 04/16/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: Joint bone pain entire body still have it; hands, wrists, ankles and feet had shooting burning pains; can't function, type, cook, or anything; hands, wrists, ankles and feet had shooting burning pains; This is a spontaneous report from a contactable consumer (patient) received via the regulatory authority. A non-pregnant 54-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration, administered on the left arm on 17Mar2021 05:15 (Lot Number: Eng204) (at the age of 54 years old) as dose 1, single for COVID-19 immunisation (also reported as dose number 2 on 17Mar2021 at 17:15 Lot Number: En6204; for confirmation). The vaccine was administered in a Pharmacy or Drug Store. The patient's medical history included asthma, inflammatory bowel disease, and known allergies: penicillin and latex. Concomitant medications included ipratropium bromide;salbutamol sulfate (COMBIVENT), montelukast, and "ALBATROS" for unspecified indications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination nor was tested for COVID-19 since vaccination. On 16Apr2021 02:00, the patient experienced "Joint bone pain entire body still have it". The patient can't function, type, cook, or anything. The hands, wrists, ankles, and feet had shooting burning pains. The events resulted in a Doctor or other healthcare professional office/clinic visit and Emergency room/department or urgent care. The patient received prednisone as a treatment. The patient has not recovered from the events. No follow-up attempts are possible. No further information is expected.

Other Meds: COMBIVENT; MONTELUKAST

Current Illness:

ID: 1811182
Sex: F
Age:
State: CA

Vax Date: 04/17/2021
Onset Date: 04/17/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data: Test Date: 20210421; Test Name: Nasal Swab; Result Unstructured Data: Test Result:Unknown results; Test Date: 20210419; Test Name: Nasal Swab; Test Result: Negative

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: Extremely exhausted; Sleeping 15, 16 hours straight; Burning lungs; Severe body aches; Severe tinnitus; 5 full days of illness / "I" am a mess.; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FW0K9) via an unspecified route of administration in the right arm on 17Apr2021 at 11:00 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Medical history included tinnitus that lasted two months and elevated cholesterol. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. On 17Apr2021, the patient was extremely exhausted, slept for 15-16 hours straight, had burning lungs, severe body aches and severe tinnitus running 5 days. It was reported that a vaccine should not produce 5 full days of illness and it was too strong. The patient also questioned for how long these effects go on? The patient had to go to work throughout this because no one could replace. It was like having COVID all over again. The patient felt fine before but at the time of reporting was a mess. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of adverse events. Since the vaccination, the patient had been tested for COVID-19. On 19Apr2021, the patient underwent COVID-19 test via nasal swab and the result was negative. On 21Apr2021, the patient underwent COVID-19 test via nasal and the result was unknown. The clinical outcome of the event extremely exhausted, slept 15-16 hours straight, burning lungs, severe body aches, severe tinnitus, illness was a mess was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1811183
Sex: F
Age:
State: DE

Vax Date: 04/18/2021
Onset Date: 04/19/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: The roof of my mouth and my gums became very inflamed/swollen; The roof of my mouth and my gums became very inflamed/swollen; The roof of my mouth and my gums became very inflamed/swollen; This is a spontaneous report from a contactable consumer (patient). A 61-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 2 via an unspecified route of administration, administered in Arm Left on 18Apr2021 12:00 (Batch/Lot Number: EW0164) as single dose for covid-19 immunisation. Medical history included rheumatoid arthritis, penicillin allergy. The patient had received the first dose of the same vaccine from Lot number=ER8732 on 30Mar2021 01:00 PM at the age of 61 years old, at the left arm. The patient experienced the roof of my mouth and my gums became very inflamed/swollen on 19Apr2021 with outcome of recovering. The patient received treatment for the events, IV Steroid, and a prescription for Oral steroids. The patient was not pregnant. No covid prior vaccination, the patient was not tested post vaccination. The events were assessed as serious.

Other Meds:

Current Illness:

ID: 1811184
Sex: F
Age:
State: KY

Vax Date: 04/20/2021
Onset Date: 04/21/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: Abdominal pain; Vomiting; Diarrhea; Sweating; Chills; Migraine; Sore arm; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 22-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on 20Apr2021 at 11:30 (at the age of 22-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies to food, medications or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19.The patient did not receive any medication within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on 22Mar2021 at 18:45 (at the age of 21-years-old) as a single dose for COVID-19 immunisation. On 21Apr2021 at 08:15, the patient experienced abdominal pain, vomiting, diarrhea, sweating, chills, migraine, sore arm and fatigue . No therapeutic measures were taken as a result of events. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. Since the vaccination, the patient had not been tested for COVID-19.The clinical outcome of the event Abdominal pain, vomiting, diarrhea, sweating, chills, migraine, sore arm, fatigue was resolved on an unknown date in Apr2021. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1811185
Sex: F
Age:
State: NC

Vax Date: 03/09/2021
Onset Date: 03/12/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: I have afib. After second dose, my Afib gradually worsened.; I have afib. After second dose, my Afib gradually worsened.; At 3 weeks out it peaked with very irregular heartbeat, flopping, skipping beats; flopping; skipping beats; This is a spontaneous report from a contactable consumer (Patient) or other non HCP. A 70-years-old (non-pregnant) female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: EM9809, Expiry date was not reported), via an unspecified route of administration on 09Mar2021 (at the age of 70-years-old) in Arm Right as dose 2, single for COVID-19 immunization. The Patient Medical history included atrial fibrillation from an unknown date and unknown if ongoing, food allergy from an unknown date and unknown if ongoing known allergies Sulphur, shellfish. Concomitant medication(s) included propafenon; retinol palmitate, vitamin d nos (VIT A+D); colecalciferol, menadione (VITAMIN K+D); calcium; magnesium; acetylsalicylic acid (ASPIR) all taken for an unspecified indication, start and stop date were not reported. The patient previously took sulphur for drug hypersensitivity. Previously patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection, Batch/Lot Number: EM9810 and Expiry date was not reported), via an unspecified route of administration on 16Feb2021, 06:45 PM in Arm Right as dose 1, single for COVID-19 immunization. The Patient was not pregnant at the time of vaccination. The patient was not received other vaccines in four weeks. The Patient was not diagnosed with COVID prior vaccination and Patient was not tested COVID post vaccination. On 12Mar2021, 13:15, the patient experienced she have afib. after second dose, her afib gradually worsened. At 3 weeks out it peaked with very irregular heartbeat, flopping, skipping beats. Totally cut out caffeine and white sugar. 5 days later it finally got back to normal. Thinking it might be related to the vaccine. The Patient visited Physician office. The Patient visited emergency room for event Flopping. The Patient had not received the treatment for the events. The outcome for all the events was recovered with sequel on unspecified date in 2021. No follow-up attempts are needed. No further information is expected.

Other Meds: PROPAFENONE; VIT A+D; VITAMIN K+D; CALCIUM; MAGNESIUM; ASPIR

Current Illness:

ID: 1811186
Sex: F
Age:
State: NY

Vax Date: 04/21/2021
Onset Date: 04/21/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: When I woke up in the morning, pain was gone, but entire body is weak; About 8 hours after receiving the vaccine, i started getting feverish and had a headache.; About 8 hours after receiving the vaccine, i started getting feverish and had a headache.; Slowly started having severe pain in both legs from my waist down to my toes for about 6 hours; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0169) via an unspecified route of administration in the right arm on 21Apr2021 at 08:00 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history and had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medication within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the right arm on 31Mar2021 at 08:00 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 21Apr2021 at 16:00, about 8 hours after receiving the vaccine, the patient started getting feverish and had a headache. Slowly she started having severe pain in both legs from her waist down to her toes for about 6 hours. When the patient woke up in the morning, pain was gone, but entire body was weak and still had a headache. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event slowly started having severe pain in both legs from waist down to toes for about 6 hours was resolved the next morning on 22Apr2021. The clinical outcome of the events about 8 hours after receiving the vaccine, started getting feverish and of entire body was weak was resolving, while that of headache was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1811187
Sex: F
Age:
State: OH

Vax Date: 04/15/2021
Onset Date: 04/16/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: Am experiencing heavy vertigo/dizziness 6 days later. has been happening for over 24 hours.; Am experiencing heavy vertigo/dizziness 6 days later. has been happening for over 24 hours.; Normal arm soreness the day after. severe pain in same arm 5 days later, for roughly 6 hours; This is a spontaneous report from a contactable consumer, the patient. A 27-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the right arm on 15Apr2021 at 17:00 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications taken within two weeks of vaccination included bupropion (MANUFACTURER UNKNOWN), gabapentin (MANUFACTURER UNKNOWN), trazodone hydrochloride (DEPRAX) and duloxetine hydrochloride (CYMBALTA); all for unknown indication on unknown date and unknown if ongoing. The patient previously took buspirone (MANUFACTURER UNKNOWN) and experienced drug allergy. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient experienced normal arm soreness the day after on 16Apr2021, and severe pain in same arm 5 days later, for roughly 6 hours. The patient also experienced heavy vertigo and dizziness 6 days later on 21Apr2021 and it had been happening for over 24 hours. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events normal arm soreness the day after, severe pain in same arm 5 days later, for roughly 6 hours; experienced heavy vertigo and dizziness 6 days later and it had been happening for over 24 hours was unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: BUPROPION; GABAPENTIN; DEPRAX [TRAZODONE HYDROCHLORIDE]; CYMBALTA

Current Illness:

ID: 1811188
Sex: F
Age:
State: NY

Vax Date: 04/12/2021
Onset Date: 04/14/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data: Test Date: 20210414; Test Name: Nasal swab; Test Result: Negative

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: Red rash formed on neck; Patch on elbow of right arm, rash is all over neck, behind one ear, multiple patches on right arm; A few small bumps on left arm; Arms itch; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 12Apr2021 (at the age of 36-year-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medication included unspecified medication for birth control from unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. On 14Apr2021, 2 days after the vaccination, the patient experienced red rash formed on her neck. Next morning, another patch on elbow of her right arm. Now it was been a week and the rash were all over her neck, behind her one ear, multiple patches on her right arm. And a few small bumps on left arm. Arms itch. Neck not as much. The events did not result in doctor or other healthcare professional office/clinic visit/emergency visit. Therapeutic measures were not taken as a result of events. Since the vaccination, the patient had been tested for COVID-19. On 14Apr2021, the patient underwent nasal swab test and the result was negative. The clinical outcome of the events red rash formed on neck, patch on elbow of right arm, rash was all over neck, behind one ear, multiple patches on right arm, a few small bumps on left arm and arms itch was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1811189
Sex: M
Age:
State: IN

Vax Date: 04/15/2021
Onset Date: 04/16/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210416; Test Name: Body temperature; Result Unstructured Data: Test Result:Increased; Comments: at 02:00

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: Within 36hrs, experienced extreme abdominal pains on the left side of the abdomen; Within 12hrs of dose, experienced flu-like symptoms; Elevated body temperature (no fever); Aches; Headache; Nausea; Fatigue; This is a spontaneous report from a non-contactable consumer, the patient. A 42-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on 15Apr2021 at 13:00 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the left arm on 25Mar2021 at 12:00 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. On 16Apr2021 at 02:00, within 12 hours of dose, the patient experienced flu-like symptoms with elevated body temperature (no fever), aches, headache, nausea, and fatigue. On 17Apr2021 at 01:00, within 36 hours, the patient experienced extreme abdominal pains on the left side of his abdomen, which passed within 12 hours. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. On 16Apr2021 at 02:00, the patient underwent body temperature test and the result was increased. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events within 12 hours of dose, experienced flu-like symptoms, elevated body temperature (no fever), aches, headache, nausea and fatigue was resolved on an unknown date in Apr2021 while the event within 36 hours, experienced extreme abdominal pains on the left side of the abdomen was resolved on 17Apr2021 at 13:00. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1811190
Sex: F
Age:
State: WA

Vax Date: 04/16/2021
Onset Date: 04/01/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: Violently ill; weakened on left side of body mostly from left hip down but now also shoulder; Weekends on left side of body mostly from left hip down but now also shoulder; Feeling extreme disorientation; Extremely scary; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6198) via an unspecified route of administration in the right arm on 16Apr2021 at 09:00 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history (reported as perfectly healthy). The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The patient did not receive any other medications within two weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6198) via an unspecified route of administration in the right arm on 26Mar2021 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. On 16Apr2021 at 21:00, 12 hours after vaccination, the patient experienced violently ill and could not get out of bed for 2 days and got better. On an unknown date in Apr2021 (also reported as week later), the patient experienced weakened on left side of body mostly from left hip down but now also shoulder, last night in the middle of the night, the patient woke up feeling extreme disorientation almost like she was in bed but was going to fall. The patient got out of bed crawled in all fours trying to get himself settled. The patient was able to get out of it slightly. It was extremely scary now patient felt the same left side weakness and nausea overall not feeling well at all. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events violently ill, weakened on left side of body mostly from left hip down but now also shoulder, extreme disorientation, scary and nausea was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1811191
Sex: F
Age:
State: UT

Vax Date: 04/16/2021
Onset Date: 04/16/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: Severe whole arm pain (injection arm couldn't use); Severe dizziness; Severe tiredness; Bad metallic taste in mouth; Moderate body pain; Mild nausea; This is a spontaneous report from a non-contactable consumer, the patient. A 46-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0138) via an unspecified route of administration in the left arm on 16Apr2021 at 10:30 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma, upper respiratory allergies and known allergy to soy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included metronidazole (MANUFACTURER UNKNOWN), glycopyrronium bromide, formoterol fumarate, budesonide (BREZTRI AEROSPHERE) and levocetirizine (MANUFACTURER UNKNOWN); all taken for an unknown indication, from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took acetylsalicylic acid (ASPIRIN) and experienced drug allergy. On 16Apr2021 at 13:00, 2.5 hours after injection, the patient experienced severe whole arm pain (injection arm couldnt use), severe dizziness, severe tiredness, bad metallic taste in mouth, moderate body pain and mild nausea which lasted for 48 hours. After 48 hours the symptoms started to wane and resolved after 72 hours. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events experienced severe whole arm pain (injection arm couldnt use), severe dizziness, severe tiredness, bad metallic taste in mouth, moderate body pain and mild nausea was recovered on 19Apr2021 at 13:00. No follow-up attempts are possible. No further information is expected.

Other Meds: METRONIDAZOLE; BREZTRI AEROSPHERE; LEVOCETIRIZINE

Current Illness:

ID: 1811192
Sex: F
Age:
State: NC

Vax Date: 04/04/2021
Onset Date: 04/04/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: Nausea; Diarrhea; Headache; Dizziness; No appetite; Balance issues; Lungs hurt; Muscle aching; Chills; Dose 1: 27Mar2021, Dose 2: 04Apr2021; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EWO169) via an unspecified route of administration in the left arm on 04Apr2021 at 10:00 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma and undifferentiated connective tissue disease (utcd). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received unspecified medication within two weeks of vaccination. The patient previously received nitrofurantoin (MACROBID) for unknown indication on an unknown date and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 27Mar2021 at 10:00 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. On 20Apr2021 at 10:30, the patient experienced nausea, diarrhea, headache, dizziness, no appetite, balance issues, lungs hurt, muscle aching and chills. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events nausea, diarrhea, headache, dizziness, no appetite, balance issues, lungs hurt, muscle aching and chills was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1811193
Sex: F
Age:
State:

Vax Date: 04/16/2021
Onset Date: 04/17/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: Sensitive to the touch at the time I am writing this (60 hours after vaccine).; 36 hours after the shot it was visibly swollen and painful; Left armpit started swelling 24 hours after shot; 36 hours after the shot it was visibly swollen and painful. No visible lymph nodes, just general swelling. Swelling went down after ~48 hours but still somewhat painful and sensitive to the touch; This is a spontaneous report from a non-contactable consumer, the patient. A 29-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the left arm on 16Apr2021 at 17:00 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included unspecified birth control medications from an unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 24Mar2021 at 17:15 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. On 17Mar2021 at 17:00, 24 hours after shot the patient's left armpit started swelling; 36 hours after the shot on 18Mar2021 at 05:00, it was visibly swollen and painful. No visible lymph nodes, just general swelling. Swelling went down after 48 hours but still somewhat painful. Swelling was sensitive to the touch on 20Apr2021 at 08:47 the time, the patient was writing this report (also reported as 60 hours after vaccine). The events were reported because the patient read that swollen gland were only found in 0.3 percentage of Pfizer vaccine patients, but it may be more common. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events, left armpit started swelling 24 hours after shot; 36 hours after the shot it was visibly swollen and painful, swelling went down after 48 hours but still somewhat painful and sensitive to the touch were resolving at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1811194
Sex: F
Age:
State:

Vax Date: 03/18/2021
Onset Date: 03/01/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: Heavy, irregular period in timeframe after vaccine spotting bleeding for about a month, then heavier than usual flow; Heavy, irregular period in timeframe after vaccine spotting bleeding for about a month, then heavier than usual flow; Heavy, irregular period in timeframe after vaccine spotting bleeding for about a month, then heavier than usual flow; More painful than usual cramps at expected period date.; This is a spontaneous report from a non-contactable consumer, the patient. A 28-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on 18Mar2021 (at the age of 28-years-old) and a second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the left arm on 08Apr2021 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication taken within two weeks of vaccination included ethinylestradiol, ferrous fumarate, norethisterone acetate (LO LOESTRIN FE) for unknown indication on unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in Mar2021 the patient experienced heavy, irregular period in timeframe after vaccine. There was spotting bleeding for about a month, then heavier than usual flow and more painful than usual cramps at expected period date. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events experienced heavy, irregular period in timeframe after vaccine; spotting bleeding for about a month, then heavier than usual flow and more painful than usual cramps at expected period date was resolving at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds: LO LOESTRIN FE

Current Illness:

ID: 1811195
Sex: F
Age:
State: CT

Vax Date: 04/19/2021
Onset Date: 04/19/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: Terrible diarrhea; Weakness in legs where "I" could not stand up; Chills; Broke out in a cold sweat; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the right arm on 19Apr2021 at 17:45 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. Medical history included type 2 diabetes, high blood pressure, high cholesterol, depression, anxiety, hypothyroidism, penicillin allergy and allergy to all fruits and fruit pectin. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included dulaglutide (TRULICITY) and lisinopril (MANUFACTURER UNKNOWN); both for unknown indication from an unknown start date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the right arm on 22Mar2021 at 17:45 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. On 19Apr2021 at 20:45 (also reported as 21:00), approximately 3 hours after the vaccination, the patient experienced terrible diarrhea, weakness in the legs where the patient could not stand up, broke out in a cold sweat and also had chills. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event terrible diarrhea, weakness in the legs where the patient could not stand up, broke out in a cold sweat and chills was resolved on an unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds: TRULICITY; LISINOPRIL.

Current Illness:

ID: 1811196
Sex: F
Age:
State: NC

Vax Date: 04/21/2021
Onset Date: 04/21/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: After dinner time, about 6pm signs started showing: shallow breathing; Fast heartbeat; Weakness; Strong pain in arm; Strong pain in wrist; Strong pain in neck; Face and neck felt puffy; Feeling unwell; Tired; Joint pain; Awoke a few times at night with strong nausea; This is a spontaneous report received from a contactable consumer, the patient. A 40-year-old non pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 21Apr2021 at 10:00 (at the age of 40-year-old) as a single dose for COVID-19 immunisation. Medical history included herpes (herpes virus infection) for which patient took valtrex occasionally. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. Concomitant medications included valaciclovir hydrochloride (VALTREX) for herpes from unknown date and unknown if ongoing. On 21Apr2021 at 18:00, after dinner time, the patient experienced shallow breathing, fast heartbeat, weakness, strong pain in arm, wrist and neck, face and neck felt puffy, feeling unwell, tired, joint pain and awoke a few times at night with strong nausea. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. Therapeutic measures were taken as a result of events strong pain in arm, wrist and neck, face and neck and joint pain which included treatment with paracetamol (TYLENOL) which helped with the pain. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events shallow breathing, fast heartbeat, weakness, strong pain in arm, wrist and neck, face and neck felt puffy, feeling unwell, tired, joint pain and awoke a few times at night with strong nausea was resolved on an unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds: VALTREX

Current Illness:

ID: 1811197
Sex: F
Age:
State: MN

Vax Date: 04/15/2021
Onset Date: 04/15/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: About an hour after -heart raced; Felt nauseous; Headache; Dizzy; Almost passed out hot flash; Felt like couldn't breath; Mild rash face/arm/legs/torso; A week later today still icky; Sore throat; almostpassed out; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 15Apr2021 at 12:30 (at the age of 63-year-old) as a single dose for COVID-19 immunisation. Medical history included below right below knee amputation, right arm amputation and stoma. The patient had known many allergies (unspecified) to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included ibuprofen (MANUFACTURER UNKNOWN), acetylsalicylic acid (ASPIRIN), magnesium (MANUFACTURER UNKNOWN), levothyroxine (MANUFACTURER UNKNOWN), alprazolam (XANAX) and tapentadol hydrochloride (NUCYNTA); all for unspecified indication, from an unknown date and unknown if ongoing. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On 15Apr2021 at 13:30, about an hour after vaccination, the patient experienced heart raced, felt nauseous, headache, dizzy, almost passed out, hot flash, felt like could not breathe, mild rash on face, arm, legs, torso. A week later today still patient felt icky but had not major symptoms, but had little dizzy, sore throat and headache. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events heart raced, felt nauseous, headache, dizzy, almost passed out, hot flash, could not breathe, almost passed out, mild rash face, arm, legs, torso, still icky, little dizzy, sore throat, and headache were resolving at the time of report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: IBUPROFEN; ASPIRIN; MAGNESIUM; LEVOTHYROXINE; XANAX; NUCYNTA

Current Illness:

ID: 1811198
Sex: F
Age:
State: SC

Vax Date:
Onset Date: 04/05/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: Swelling of arm; Large red circle at the injection site; Severe pain in left hip/ left wrist.; Also severe pain in left hip and left wrist; This is a spontaneous report from a contactable consumer, the patient. A 72-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FR8727) via an unspecified route of administration in the left arm on 31Mar2021 at 12:00 (at the age of 72-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medications included losartan (MANUFACTURER UNKNOWN) for blood pressure from an unknown date and unknown if ongoing. The patient previously received doxycycline (MANUFACTURER UNKNOWN) and experienced drug allergy. On 05Apr2021, the patient experienced swelling of arm and large red circle at the injection site. The patient also had severe pain in left hip and left wrist. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the events which included treatment with unspecified antibiotic . Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events swelling of arm, large red circle at the injection site, also severe pain in left hip and left wrist was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: LOSARTAN

Current Illness:

ID: 1811199
Sex: M
Age:
State: IL

Vax Date: 04/21/2021
Onset Date: 04/21/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210421; Test Name: Body temperature; Result Unstructured Data: Test Result:102.7 Fahrenheit; Comments: Fever

Allergies:

Symptom List: Injection site pain

Symptoms: Chills; body aches; joint aches; fever (102.7 F); This is a spontaneous report from a contactable consumer reported for a patient. A 40-years-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: ER2613, Expiration date: unknown) via an unspecified route of administration, administered in left arm on 21Apr2021 at 09:00 am (age at vaccination was 40 years) as dose 2, single for COVID-19 immunization. The patient did not have any medical history. The patient did not have any known allergies. The patient did not receive any concomitant medications or other medications in two weeks. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: EJ1985, Expiration date: unknown) via an unspecified route of administration, administered in left arm on 30Mar2021 at 09:15 am (age at vaccination was 40 years) as dose 1, single for COVID-19 immunization. The facility where the most recent COVID-19 vaccine was administered was Workplace clinic. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On 21Apr2021 at 23:00 pm, the patient experienced chills, body aches, joint aches and fever (102.7 F). The patient underwent lab test which included body temperature: 102.7 Fahrenheit (Fever) on 21Apr2021. No treatment was received for the adverse events. The outcome of the events was not resolved. No follow up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1811200
Sex: F
Age:
State: OH

Vax Date: 04/21/2021
Onset Date: 04/22/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Intense wave of nausea; Diarrhea; Sinus headache; Body aches (concentrated in lower back, legs, and feet); Injection site soreness; Mild dizziness; This is a spontaneous report from a non-contactable consumer, the patient. A 34-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 21Apr2021 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history included mild asthma, fibromyalgia, IBS (irritable bowel syndrome), depression and anxiety. Concomitant medications included gabapentin (NEURONTIN), sertraline hydrochloride (ZOLOFT), levocetirizine dihydrochloride (XYZAL), ethinylestradiol/norgestimate (TRI-PREVIFEM) and colecalciferol (VITAMIN D3); all for unknown indications from unknown dates and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took chlorhexidine (MANUFACTURER UNKNOWN) and bupropion hydrochloride (WELLBUTRIN) and experienced drug allergy. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 31Mar2021 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. On 22Apr2021, side effects began 14 hours after second dose, waking the patient up from sleep and the patient experienced intense wave of nausea, diarrhea, sinus headache, body aches (concentrated in lower back, legs, and feet), injection site soreness and mild dizziness. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events intense wave of nausea, diarrhea, sinus headache, body aches (concentrated in lower back, legs, and feet), injection site soreness and mild dizziness was resolving at the time of the report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: NEURONTIN; ZOLOFT; XYZAL; TRI-PREVIFEM; VITAMIN D3.

Current Illness:

ID: 1811201
Sex: F
Age:
State: NY

Vax Date: 04/06/2021
Onset Date: 04/19/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: My period is early. This is remarkable because I am on birth control; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the arm left on 06Apr2021 at 08:15 (at the age of 29-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not have any known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included unspecified medication for birth control from an unknown date and unknown if ongoing. On 19Apr2021, the patient's period was early which the patient thought was remarkable since the patient was on birth control. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event period is early was unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1811202
Sex: M
Age:
State: NY

Vax Date: 04/21/2021
Onset Date: 04/22/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210422; Test Name: Body temperature; Result Unstructured Data: Test Result: 100 Units: [degF]; Comments: ~100F.

Allergies:

Symptom List: Tremor

Symptoms: Fever, ~100F; Chills; Body aches; Shortness of breath; Cough; Headache; Injection arm painful to lift; Pain in muscles of back; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8936) via an unspecified route of administration in the left arm on 21Apr2021 at 11:30 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies. The patient did not receive any medications within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ep7533) via an unspecified route of administration in the left arm on 31Mar2021 at 11:30 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. On 22Apr2021 at 08:00, the patient experienced fever, about 100 Fahrenheit, chills, body aches, shortness of breath, cough, headache, injection arm painful to lift, and pain in muscles of back. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever, about 100 Fahrenheit, chills, body aches, shortness of breath, cough, headache, injection arm painful to lift and pain in muscles of back was unknown at the time of the report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1811203
Sex: M
Age:
State: AZ

Vax Date: 03/04/2021
Onset Date: 03/06/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: Immediate onset of severe Tinnitus; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 6202) via an unspecified route of administration in the left arm on 04Mar2021 at 08:00 (at the age of 61-year-old) as a single dose for COVID-19 immunisation. Medical history included tentative diagnosis of otosclerosis. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had no known allergies. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included rosuvastatin calcium (CRESTOR), acetylsalicylic acid (ASPIRIN), famotidine (PEPCID AC) and oxazepam (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date and unknown if ongoing. On 06Mar2021 at 10:00, the patient experienced immediate onset of severe tinnitus. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of immediate onset of severe tinnitus, visited to ENT on an unknown date. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event immediate onset of severe tinnitus was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: CRESTOR; ASPIRIN [ACETYLSALICYLIC ACID]; PEPCID AC; OXAZEPAM

Current Illness:

ID: 1811204
Sex: F
Age:
State: DC

Vax Date: 04/09/2021
Onset Date: 04/18/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: cramping with menstrual cycle; Bloating; Period heavier and longer; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the right arm on 09Apr2021 at 11:30 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medications included vitamin c (MANUFACTURER UNKNOWN); vitamin d (MANUFACTURER UNKNOWN) and zinc (MANUFACTURER UNKNOWN); all for unknown indication from unknown date and unknown if ongoing. On 18Apr2021, the patient experienced period was heavier and longer than it had been in 6 years. She also experienced bloating and cramping with menstrual cycle which was highly out of the ordinary for the patient. The events did not result in a visit to the doctors or other healthcare professional office/clinic, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events period heavier and longer, bloating and cramping with menstrual cycle was unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: VITAMIN C [ASCORBIC ACID]; VITAMIN D [VITAMIN D NOS]; ZINC

Current Illness:

ID: 1811206
Sex: M
Age:
State: OR

Vax Date: 04/22/2021
Onset Date: 04/22/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: I got very tired within 10 minutes.; I started sweating profusely; Then I got the sudden urge to poop; As I walked to the bathroom I almost passed out from extreme dizziness; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the right arm on 22Apr2021 at 15:30 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient did not have any allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive concomitant medications. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 22Apr2021 at 15:30, the patient got very tired within 10 minutes, then the patient started sweating profusely, also got the sudden urge to poop and as the patient walked to the bathroom, he almost passed out from extreme dizziness. The patient continued sweating and being very dizzy for about 5 more minutes, then the patient felt better. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events very tired within 10 minutes, sweating profusely, sudden urge to poop and dizziness was recovered on 22Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1811207
Sex: F
Age:
State: VA

Vax Date: 04/20/2021
Onset Date: 04/21/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: 50 hours after injection, I had another ill feeling; Lightheaded; Throbbing headache and was bed ridden the whole next day; Severe cold chills for 4 hours; My body started aching; All of my joints aches like arthritis. My wrists, ankles, knees and hips; Got a heat flash that lasted 3 hours; was sweating and my skin felt like sunburnt; This is a spontaneous report from a contactable other healthcare professional, the patient. A 35-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on 20Apr2021 at 10:00 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medication included ethinylestradiol, norethisterone acetate (JUNEL) for birth control from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP7533) via an unspecified route of administration in the left arm on 30Mar2021, at 11:00 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. It was reported that the patient was fine for about 11 after the vaccine. On 21Apr2021 at 21:00, then the patient got severe cold chills for 4 hours. Her body started aching. All of her joints ached like arthritis. Her wrists, ankles, knees and hips. Then she got a heat flash that lasted 3 hours. She was sweating and her skin felt like sunburnt. She had a throbbing headache and was bed ridden the whole next day on 22Apr2021. It took about 36 hours after the injection to start feeling better. However, on 22Apr2021 at 12:00, 50 hours after injection, she had another ill feeling. Lightheaded and minor aches again. Lasted about an hour. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken for the events excluding body started aching. All of her joints ached like arthritis. Her wrists, ankles, knees and hips for which included treatment with ibuprofen (MOTRIN) 19 hours after the injection. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event severe cold chills for 4 hours was recovered on 22Apr2021 at 01:00. The clinical outcome of the events body started aching, all of her joints ached like arthritis, her wrists, ankles, knees and hips, was sweating and skin felt like sunburnt and throbbing headache and was bed ridden the whole next day was recovered on an unknown date in Apr2021. The clinical outcome of the event got a heat flash that lasted 3 hours was recovered on 22Apr2021 at 00:00. The clinical outcome of the event 50 hours after injection, had another ill feeling and lightheaded was resolved on 22Apr2021 at 13:00. No follow-up attempts are needed. No further information is expected.

Other Meds: JUNEL

Current Illness:

ID: 1811208
Sex: F
Age:
State: MD

Vax Date: 04/15/2021
Onset Date: 04/16/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: The day after ''my'' vaccine, about 30 hours after the shot, ''I'' began menstruating; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 15Apr2021 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history included autoimmune disorder and allergies to gluten. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included melatonin (MANUFACTURER UNKNOWN), collagen (MANUFACTURER UNKNOWN), curcuma longa rhizome (TURMERIC), Vitamin d nos (MANUFACTURER UNKNOWN) and sambucus nigra (ELDERBERRY); all for an unknown indication from an unknown date and unknown if ongoing. On 16Apr2021 at 20:00, the patient experienced not so much adverse as weird. The patient always began menstruation on or around the full moon. The day after her vaccine, about 30 hours after the shot, she began menstruating, had not stopped yet. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event about 30 hours after the shot, she began menstruating was unknown at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: MELATONIN; COLLAGEN; TURMERIC [CURCUMA LONGA RHIZOME]; VITAMIN D NOS; ELDERBERRY [SAMBUCUS NIGRA]

Current Illness:

ID: 1811209
Sex: F
Age:
State: MI

Vax Date: 01/16/2021
Onset Date: 01/18/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 202104; Test Name: estrogen level; Result Unstructured Data: Test Result:314; Comments: Normal level for postmenopausal woman is <32

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: felt similar ovulation type pain; estrogen level was tested per her request and was 314; cervical mucus change; exposed to COVID; felt like she ovulated; This is a spontaneous report from a contactable nurse received via COVID-19 Vaccine Adverse Event Reporting System. A non-pregnant 56-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), via an unspecified route of administration, administered in the right arm on 16Jan2021, at 14:30 (Lot Number: EL03248; at the age of 56 years old) as dose 2, single for COVID-19 immunisation. Medical history included postmenopausal for almost two years. The patient has no known allergies. Concomitant medication included multivitamin. She did not receive any other vaccines within four weeks prior to vaccination. The patient previously received first dose of BNT162B2, administered in the left arm on 26Dec2020, at 13:00 (Lot Number: EL0140; at the age of 55 years old) for COVID-19 immunisation. On 18Jan2021, the patient reported that she felt like she ovulated two days after the vaccine. She was 56 and almost two years postmenopausal. She was exposed to COVID in the first week of April2021 (her daughter was positive). On 01Apr2021, she felt similar ovulation type pain. On an unspecified date in Apr2021, her estrogen level was tested per her request and was 314. Normal level for postmenopausal woman is <32 (as reported). She has not had a period in two years. The patient had no other symptoms except cervical mucus change and has not had any hot flashes in at least two weeks. The patient was not diagnosed with COVID-19 prior to vaccination, and she has not been tested for COVID-19 since the vaccination. The patient did not receive any treatment for the events. The outcome of the events was unknown. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1811210
Sex: M
Age:
State: NY

Vax Date: 03/29/2021
Onset Date: 03/29/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: 90 minutes of continuous, uncontrollable, chills-shakes, about 12 hours after vaccine injection; 90 minutes of continuous, uncontrollable, chills-shakes, about 12 hours after vaccine injection; Also had 24- 36 hours of constant, severe headaches which started about 12 hours after vaccine; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 29Mar2021 at 08:00 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history. The patient had no known allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any concomitant medications. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 29Mar2021 at 20:00, about 12 hours after vaccine, the patient experienced 90 minutes of continuous, uncontrollable, chills-shakes and also had 24-36 hours of constant, severe headaches. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events 90 minutes of continuous, uncontrollable, chills-shakes were resolved on 29Mar2021; while that of the event had 24-36 hours of constant, severe headaches was resolved on an unknown date in 2021. The patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 19Apr2021 at 08:00 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1811211
Sex: F
Age:
State: FL

Vax Date: 04/07/2021
Onset Date: 04/07/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: Extreme fatigue; This is a spontaneous report from a contactable consumer, the patient. An 18-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 07Apr2021 at 10:45 (at the age of 18-years-old) as a single dose for COVID-19 immunisation. Medical history included high cholesterol. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included atorvastatin calcium (LIPITOR) for unknown indication and birth control (MANUFACTURER UNKNOWN) medication; both from unknown dates and unknown if ongoing. On 07Apr2021 at 13:00, the patient experienced extreme fatigue. The event did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event extreme fatigue was recovered on an unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds: LIPITOR

Current Illness:

ID: 1811212
Sex: F
Age:
State: IL

Vax Date: 04/17/2021
Onset Date: 04/21/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: only more severe redness to face, both sides of hands. Redness appeared on throat and arms 2nd day; Redness appeared on throat; very flushed; heated face and top and bottom of hands; Very hot touch to skin; Extreme itching on top and bottom of hands/extreme itching on the back; Extreme itching on top and bottom of hands, swelling; Extreme itching on top and bottom of hands, swelling and inflamed; nausea; vomiting; This is a spontaneous report from a contactable consumer (patient). This 50-year-old non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; lot number ER8735) via an unspecified route of administration in the left arm on 17Apr2021 at 13:00 (at 50-years-old) as a single dose for COVID-19 immunisation. Medical history included unconfirmed COVID infection in early Mar2020 to Mar2020; migraines and gastroesophageal reflux disease (GERD) reported as minor, both from unknown dates and unknown if ongoing. Concomitant medications included plecanatide (TRULANCE), lansoprazole (PREVACID), colecalciferol (D3), turmeric (curcuma longa rhizome), and fish oil, all from unknown dates for unknown indications. Prior to vaccination the patient was not diagnosed with COVID-19, had not received any other vaccines within 4 weeks of the COVID vaccine, and had no known allergies. It was reported that 4 days post-vaccination, also reported as 14Apr2021 at 12:30, the patient was very flushed and heated face and top and bottom of hands, further reported as very hot touch to skin. The patient experience extreme itching on top and bottom of hands, swelling and inflamed as well as extreme itching on the back. Two hours later, nausea and vomiting. The events resolved with 1 tablets of diphenhydramine hydrochloride (BENADRYL) after 6 hours. The same symptoms happened the next day only more severe redness to face, and both sides of hands. Redness appeared on throat and arms second day, with more nausea and vomiting. The patient went to the emergency room for treatment. The patient was treated with anti-nausea medications mixed with diphenhydramine hydrochloride in an intravenous (IV) solution. The clinical outcomes of the events were recovering. Since vaccination the patient had not been tested for COVID-19.

Other Meds: TRULANCE; PREVACID; D3; TURMERIC [CURCUMA LONGA RHIZOME]; FISH OIL

Current Illness:

ID: 1811213
Sex: M
Age:
State: PA

Vax Date: 04/13/2021
Onset Date: 04/19/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: Severe gout in left foot on the sixth day after vaccine. History of previous gout flare up especially after anesthesia but it was never this severe; Unable to walk for 4 days; This is a spontaneous report from a contactable consumer, the patient. A 74-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 13Apr2021 at 12:00 (at the age of 74-year-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure high, heart disease, unspecified on an unknown date and gout since an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included blood thinner (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date and unknown if ongoing and also received unspecified concomitant medications for blood pressure on an unknown date. The patient previously received first dose of BNT162b2 (COMIRNATY; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 16Mar2021 at 12:00 (at the age of 74-year-old) as a single dose for COVID-19 immunisation. On 19Apr2021 at 08:00, the patient experienced severe gout in left foot on the sixth day after vaccine. History of previous gout flare up especially after anesthesia but it was never this severe and unable to walk for 4 days. It was reported that patient read an article written by a doctor who observed gout in several patients after they received second COVID vaccine. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of gout aggravated and unable to walk and included treatment with colchicine (MANUFACTURER UNKNOWN). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event unable to walk was recovered on 23Apr2021, after the duration of 4 days and gout was recovering at the time of reporting. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness: Gout

ID: 1811214
Sex: F
Age:
State: NJ

Vax Date: 04/18/2021
Onset Date: 04/18/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: I started my menstrual cycle a few hours after injection.; This is a spontaneous report from a contactable consumer, the patient. A 21-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 18Apr2021 at 15:15 (at the age of 21-years-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included fluoxetine hydrochloride (PROZAC) and bupropion hydrochloride (WELLBUTRIN); both for an unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took etonogestrel (NEXPLANON) implant which prevents her from having a menstrual cycle. On 18Apr2021 at 22:00, a few hours after injection, the patient started menstrual cycle. She had a Nexplanon implant which prevented her from having a menstrual cycle. This was her first menstrual cycle in a few years. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event a few hours after injection the patient started menstrual cycle was not resolved at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: PROZAC; WELLBUTRIN.

Current Illness:

ID: 1811215
Sex: F
Age:
State: NY

Vax Date: 04/15/2021
Onset Date: 04/17/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: Menstrual cycle began heavily 2 days after receiving my second vaccine. It was not due to come for another 2 weeks, and I am never this early; Menstrual cycle began heavily 2 days after receiving my second vaccine; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 15Apr2021 at 16:30 (at the age of 37-year-old) as a single dose for COVID-19 immunisation. Medical history included anxiety, depression, premenstrual dysphoric disorder (PMDD) and allergy to penicillin. Concomitant medications included citalopram hydrobromide (CELEXA) from an unknown date and unknown if ongoing for an unknown indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 17Mar2021 at 04:30 (at the age of 37-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 17Apr2021, 2 days after the second vaccination, the patient's menstrual cycle began heavily. It was not due to come for another 2 weeks and reported that the patient's menstruation is never this early. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events menstrual cycle began heavily and it was not due to come for another 2 weeks and is never this early was not resolved at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: CELEXA [CITALOPRAM HYDROBROMIDE]

Current Illness:

ID: 1811216
Sex: F
Age:
State: UT

Vax Date:
Onset Date: 02/23/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: This is a spontaneous report from a contactable consumer (patient). A 56-year-old (non-pregnant) female patient received BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# unknown), at the age of 56, via an unspecified route of administration, on an unknown date, single dose, for COVID-19 immunisation. Medical history included asthma and COVID-19. The patient has no known allergies to food, medications or other products. The patient received unspecified medication within two weeks of vaccination. Prior to vaccination, patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On Feb 23, 2021, patient felt worse than she did when she had COVID for 3 weeks. She had extreme body aches, headaches, brain fog and extreme tiredness. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures taken as a result of the events included treatment with prednisone from an unknown date. Since the vaccination, patient has not tested for COVID-19. The outcome of the extreme body aches, headaches, brain fog and extreme tiredness resolved with lasting effects on an unknown date in 2021. No follow-up attempts required. Information about batch/lot number cannot be obtained. No further information expected.

Other Meds:

Current Illness:

ID: 1811217
Sex: F
Age:
State: MD

Vax Date: 04/18/2021
Onset Date: 04/18/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: Post-nasal drainage which started within 5 minutes of shot. Do not have allergies. Has continued over the last 24 hours. May be slightly better. No difficulty with deep breathing or swallowing.; This is a spontaneous report from a contactable consumer, the patient. A 68-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 18Apr2021 at 09:15 (at the age of 68-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. The patient did not take any concomitant medications. On 18Apr2021 at 09:15, the patient experienced post-nasal drainage which started within 5 minutes of shot. Did not have allergies. Had continued over the last 24 hours. Might be slightly better. No difficulty with deep breathing or swallowing. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the event post-nasal drainage which started within 5 minutes of shot was not recovered at the time of report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1811218
Sex: F
Age:
State: GA

Vax Date: 04/15/2021
Onset Date: 04/16/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: Extremely swollen lymph nodes; Body aches; Lethargy; Over sleeping; Trouble staying awake; Headaches; Dizziness; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0169) via an unspecified route of administration in the right arm on 15Apr2021 at 15:45 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included paroxetine hydrochloride (PAROXETINE HCL) and calcium carbonate (MANUFACTURER UNKNOWN), both taken for an unspecified indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the right arm on 25Mar2021 at 16:00 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. On 16Apr2021 at 04:00, the patient experienced extremely swollen lymph nodes, body aches, lethargy, over sleeping, trouble staying awake, headaches and dizziness. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events extremely swollen lymph nodes, body aches, lethargy, over sleeping, trouble staying awake, headaches and dizziness was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: PAROXETINE HCL; CALCIUM CARBONATE

Current Illness:

ID: 1811219
Sex: F
Age:
State: TN

Vax Date: 04/15/2021
Onset Date: 04/16/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: Extreme fatigue; Aches; Chills; Low grade fever; Dizziness; Injection site soreness; This is a spontaneous report from a contactable consumer, the patient. A 67-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the left arm on 15Apr2021 at 11:30 (at the age of 67-year-old) as a single dose for COVID-19 immunisation. Medical history included multiple sclerosis, heart disease, arthritis and COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included teriflunomide (AUBAGIO), hydrochlorothiazide,losartan potassium (LOSARTAN HCTZ), escitalopram (MANUFACTURER UNKNOWN) and baclofen (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date and unknown if ongoing. On 16Apr2021 at 13:00, the patient experienced extreme fatigue, aches, chills, low grade fever, dizziness and injection site soreness. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events extreme fatigue, aches, chills, low grade fever, dizziness and injection site soreness was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: AUBAGIO; LOSARTAN HCTZ; ESCITALOPRAM; BACLOFEN

Current Illness:

Total 2021 VAERS Injuries: 654,986

Page last modified: 13 November 2021 9:17am